IRIS
DURANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.405
EU - Europa 9.516
AS - Asia 5.855
SA - Sud America 500
Continente sconosciuto - Info sul continente non disponibili 279
AF - Africa 71
OC - Oceania 37
Totale 31.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.204
CN - Cina 2.817
GB - Regno Unito 2.615
IT - Italia 2.077
SG - Singapore 1.662
UA - Ucraina 1.375
SE - Svezia 709
RU - Federazione Russa 677
FI - Finlandia 553
TR - Turchia 499
DE - Germania 465
BR - Brasile 377
FR - Francia 353
IE - Irlanda 333
VN - Vietnam 315
IN - India 144
CA - Canada 119
PL - Polonia 84
NL - Olanda 75
HK - Hong Kong 65
JP - Giappone 63
KR - Corea 59
BD - Bangladesh 56
MX - Messico 45
ES - Italia 43
AR - Argentina 41
AU - Australia 30
AT - Austria 27
BE - Belgio 26
IQ - Iraq 26
ZA - Sudafrica 26
ID - Indonesia 22
CL - Cile 19
IR - Iran 14
PK - Pakistan 14
CO - Colombia 13
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
LT - Lituania 11
PE - Perù 11
SA - Arabia Saudita 11
CH - Svizzera 10
UZ - Uzbekistan 10
VE - Venezuela 10
MA - Marocco 9
HR - Croazia 8
HU - Ungheria 8
JM - Giamaica 8
JO - Giordania 8
PY - Paraguay 8
RO - Romania 8
CR - Costa Rica 7
EU - Europa 7
LV - Lettonia 7
MY - Malesia 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
BG - Bulgaria 6
GR - Grecia 6
HN - Honduras 6
IL - Israele 6
KE - Kenya 6
PH - Filippine 6
TN - Tunisia 6
EG - Egitto 5
SM - San Marino 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DZ - Algeria 4
KG - Kirghizistan 4
UY - Uruguay 4
AM - Armenia 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
LU - Lussemburgo 3
NG - Nigeria 3
NO - Norvegia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
KW - Kuwait 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
CI - Costa d'Avorio 1
Totale 31.368
Salva come PNG Salva come JPEG
Città #
Southend 2.316
Woodbridge 1.678
Ann Arbor 1.245
Houston 1.130
Ashburn 1.096
Jacksonville 1.092
Fairfield 1.052
Chandler 894
Singapore 858
San Jose 836
Nanjing 557
Dallas 486
Cambridge 476
Wilmington 449
Seattle 437
Beijing 428
Izmir 345
Boardman 282
Dublin 272
Council Bluffs 252
Urbino 251
Helsinki 236
Nanchang 192
New York 181
San Mateo 169
Lauterbourg 165
Princeton 161
Los Angeles 136
Hebei 118
Shenyang 118
Santa Clara 108
Changsha 98
Jiaxing 97
Ho Chi Minh City 96
Istanbul 92
Milan 89
Tianjin 87
Velikiy Novgorod 82
Rome 72
Düsseldorf 67
Buffalo 66
Hanoi 66
Hong Kong 63
Munich 59
Kunming 57
San Francisco 54
Seongnam 52
Toronto 52
Menlo Park 48
Moscow 48
São Paulo 48
London 47
San Diego 47
Dong Ket 46
Bremen 43
Shanghai 42
Nuremberg 38
Guangzhou 35
Hangzhou 35
Warsaw 35
Chicago 34
Frankfurt am Main 34
Stockholm 34
Jinan 33
Atlanta 32
Denver 32
Mülheim 32
Des Moines 31
Kraków 30
Orem 30
Tokyo 29
Changchun 28
Montreal 27
Mumbai 25
Brussels 24
Chennai 24
Ningbo 23
Brooklyn 22
Lanzhou 22
Mexico City 22
The Dalles 22
Ancona 21
Manchester 20
Palermo 20
Phoenix 20
Naples 19
Napoli 19
Norwalk 19
Amsterdam 18
Dearborn 18
Zhengzhou 18
Haikou 17
Leawood 17
Taizhou 17
Charlotte 16
Hefei 16
Johannesburg 16
Pesaro 16
Shenzhen 16
Ankara 15
Totale 20.705
Salva come PNG Salva come JPEG
Nome #
Inibitori dell’enzima NAAA (N-Acylethanolamine-Hydrolizing Acid Amidase) come nuovi agenti antinfiammatori 879
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 875
Derivatizzazione one-pot di indoli per la sintesi di triptofani, pirroloindoline, bis-indoli & co 487
Unsaturated fatty acids lactose esters: cytotoxicity, permeability enhancement and antimicrobial activity 419
Pharmacokinetics, pharmacodynamics and safety studies on URB 937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats 373
Scoperta del primo inibitore dell’enzima idrolasi delle ammidi degli acidi grassi (FAAH) ad azione periferica 359
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress 292
Cyclohexylcarbamic Acid 3’-or 4’-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis Quantitative Structure–Activity Relationships, and Molecular Modeling Studies 292
A New Synthesis of 2-Substituted DL-Tryptophan Derivatives 290
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis, Binding Affinity for Melatonin Receptor, and Evaluation of the Biological Activity 287
Sintesi e studi di relazione struttura-attività/stabilità di carbammati inibitori dell’enzima FAAH 287
A Second Generation of Carbamate-Based Fatty Acid Amide Hydrolase Inhibitors with Improved Activity in vivo 287
Antitumoral activity of indole-3-carbinol cyclic tri- and tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies 286
Structure–Property Relationships of a Class of Carbamate-Based Fatty Acid Amide Hydrolase (FAAH) Inhibitors: Chemical and Biological Stability 270
Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: Steric effects of N-alkyl chain on rat plasma and liver stability 268
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus 267
Lactose oleate as new biocompatible surfactant for pharmaceutical applications 261
The Synthetic Cannabinoid URB447 Reduces Brain Injury and the Associated White Matter Demyelination After Hypoxia-Ischemia in Neonatal Rats 260
A combination of sugar esters and chitosan to promote in vivo wound care 260
Identification of a Bioactive Impurity in a Commercial Sample of 6-Methyl-2-p-tolylaminobenzo[d][1,3]oxazin-4-one (URB754) 259
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3’-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice 256
Synthesis, Structure-Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers 253
2-Bromomelatonin: Synthesis and characterization of a potent melatonin agonist 251
Synthesis and Evaluation of Saccharide-Based Aliphatic and Aromatic Esters as Antimicrobial and Antibiofilm Agents 247
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation 246
Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24-Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 246
Anandamide suppressess pain initiation through a peripheral endocannabinoid mechanism 239
Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines 236
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 235
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 235
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats 228
A practical and expeditious method for the preparation of the anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet) 226
An endocannabinoid mechanism for stress-induced analgesia 222
O-Biphenyl-3-yl Carbamates as Peripheral FAAH Inhibitors: Synthesis and Structure–Activity (SAR) Relationship Studies 222
Mechanisms of action and antiproliferative properties of URB631 in human breast cancer 219
Peripherally Restricted FAAH Inhibitors 217
Synthesis and Structure–Activity Relationships of a Series of Pyrrole Cannabinoid Receptor Agonists 215
Synthesis and Structure–Activity Relationship (SAR) of 2-Methyl-4-oxo-3-oxetanyl Carbamic Acid Esters, a Class of Potent N-Acylethanolamine Acid Amidase (NAAA) Inhibitors 215
The indole-3-carbinol tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines 215
A Versatile Biomimetic Approach to Diindolylmethane Derivatives as Potential Anticancer Agents 213
Indole-3-carbinol (I3C) Tetrameric Derivative (CTet) Inhibits Cell Cycle Progression Inducing Overexpression of p21/cip1/waf1 and GADD45A in Breast Cancer Cell Lines 213
Synthesis and Quantitative Structure–Activity Relationship of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates 211
2-Substituted-5-Methoxy-N-acyltryptamines: Synthesis and Binding Affinity to the Melatonin Receptor 209
Sintesi e studi biologici preliminari su analoghi di URB937, il primo inibitore ad azione periferica dell'enzima FAAH 206
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain 206
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 204
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models 204
2 - Arachidonoylglycerol and anandamide are endocannabinoid mediators of stress - induced analgesia 201
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus 197
Design, Synthesis and Structure–Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase Inhibitors 197
N-(2-Oxo-3-oxetanyl)carbamic Acid Esters as N-Acylethanolamine Acid Amidase Inhibitors: Synthesis, Structure–Activity and Structure–Property Relationships 195
Antimyotonic effects of enantiomers of mexiletine-like drugs 194
Modulation of anxiety through blockade of anandamide hydrolysis 194
URB602 Inhibits Monoacylglycerol Lipase and Selectively Blocks 2-Arachidonoylglycerol Degradation in Intact Brain Slices 193
Therapeutic Effects of Tocainide and Mexiletine Analogs on Myotonic MTO and ADR Mice 193
Derivato tetramerico ciclico dell’indol-3-carbinolo CTet come chemiopreventivo in tumori al seno estrogeno-dipendenti 192
Synthesis and Structure–Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors 191
α-Acylamino-β-lactones as a new class of N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitors: synthesis and structure–activity relationships 189
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 189
Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice 188
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat 188
SYNTHESIS AND EVALUATION OF SUGAR-BASED ALIPHATIC AND AROMATIC FATTY ACID ESTERS AS ANTIMICROBIAL AND ANTIBIOFILM AGENTS 188
Synthesis and Structure–Activity Relationships of FAAH Inhibitors: Cyclohexylcarbamic Acid Biphenyl Esters with Chemical Modulation at the Proximal Phenyl Ring 186
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition 185
The CB1 Antagonist/CB2 Agonist URB447 Confers Neuroprotection after Neonatal Hypoxia-ischemia 185
Synthesis and Structure–Activity Relationship Studies of O-Biphenyl-3-yl Carbamates as Peripherally Restricted Fatty Acid Amide Hydrolase Inhibitors 185
Synthesis and Structure-Activity/Stability Relationships of Carbamate Inhibitors of the FAAH Enzyme 183
The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues 183
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597) 182
Sintesi e studi di relazione struttura–attività/selettività su O-bifenil-3-ilcarbammati disostituiti quali inibitori periferici dell’enzima FAAH 182
Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels 180
N-alchil-O-arilcarbammati come inibitori delle idrolasi delle ammidi degli acidi grassi (FAAH): aspetti meccanicistici 179
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity 179
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors 177
A linear relationship between MS/MS data and FAAH inhibitory activity of some carbamates 176
Identification of a Bioactive Impurity Present in a Sample of URB754 173
Analoghi chirali della mexiletina: attività sui canali ionici 172
Selective inhibition of 2 - AG hydrolysis enhances endocannabinoid signaling in the hippocampus 171
Contribution to the Study of 2-Aryloxy-1-phenyl and 2-Aryloxy-2-phenylethanols. Differentiation by Mass Spectrometry 166
3D-QSAR study of carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 165
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3'-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation 163
Synthesis and Biological Characterization of the New Glycolipid Lactose Undecylenate (URB1418) 161
2,6-Xilididi e β-2,6-xililossietilammine come ligandi anfipatici per i recettori benzodiazepinici di tipo mitocondriale 160
Stereospecific synthesis of mexiletine and related compounds: Mitsunobu versus Williamson reaction 159
Antinociceptive effects of the brain-impermeant fatty-acid amide hydrolase inhibitor URB937 159
Design, SAR and Biological Activity of a New Class of FAAH Inhibitors: Cyclohexyl Carbamic Acid Biphenyl-3-yl Esters 158
Synthesis and pharmacological characterization of URB447, a new cannabinoid receptor neutral antagonist 157
Antinoceptive Effects of the N-Acylethanolamine Acid Amidase Inhibitor ARN077 in Rodent Pain Models 155
Inhibitors of lysosomal lipid amidase NAAA 153
Relationships Between Mass Spectrometry and Biological Stability of Some N-Acylethanolamine Acid Amidase Inhibitors 153
Tandem mass spectrometric data–FAAH inhibitors activity relationships of some carbamic acid O-aryl esters 152
Anestetici locali (Cap. 14) 152
Chronic stimulation of the endogenous anandamide tone reduces cocaine-seeking and cue-induced relapse in rats 149
Synthesis and Biological Evaluation of 6-O-Sucrose Monoester Glycolipids as Possible New Antifungal Agents 149
QSAR and molecular modelling investigations of a new series of alkyl carbamic acid aryl ester inhibitors of fatty acid amide hydrolase 147
URB602, a Monoacylglycerol Lipase Inhibitor, Protects from the Long-term Consequences of a Neonatal Hypoxic-ischemic Brain Injury in Rats 146
Structure-Activity Relationships of Alkylcarbamic Acid Aryl Esters, as Fatty Acid Amide Hydrolase Inhibitors 146
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 145
Design, Synthesis and SAR of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acids Amide Hydrolase Inhibitors 145
Total Synthesis of Natural Disaccharide Sambubiose 144
Totale 22.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.080
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.669 0 219 205 183 71 41 83 97 121 99 47 503
2022/20232.761 312 129 65 357 215 574 42 241 467 93 149 117
2023/2024781 96 54 56 91 54 166 37 49 15 66 28 69
2024/20252.662 139 140 619 204 97 192 296 152 244 160 237 182
2025/20266.724 538 724 779 1.069 508 457 868 264 446 533 352 186
2026/2027959 846 113 0 0 0 0 0 0 0 0 0 0
Totale 31.663